Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Catheter Precision (VTAK) over the last 9 years, with Q2 2025 value amounting to $7000.0.

  • Catheter Precision's Capital Expenditures fell 8444.44% to $7000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $17000.0, marking a year-over-year decrease of 8000.0%. This contributed to the annual value of $67000.0 for FY2024, which is 1184.21% down from last year.
  • According to the latest figures from Q2 2025, Catheter Precision's Capital Expenditures is $7000.0, which was down 8444.44% from $10000.0 recorded in Q1 2025.
  • Catheter Precision's 5-year Capital Expenditures high stood at $115000.0 for Q3 2021, and its period low was $1000.0 during Q3 2023.
  • In the last 5 years, Catheter Precision's Capital Expenditures had a median value of $20000.0 in 2021 and averaged $34000.0.
  • Per our database at Business Quant, Catheter Precision's Capital Expenditures skyrocketed by 92000.0% in 2021 and then crashed by 8444.44% in 2025.
  • Over the past 5 years, Catheter Precision's Capital Expenditures (Quarter) stood at $41000.0 in 2021, then plummeted by 58.54% to $17000.0 in 2022, then increased by 5.88% to $18000.0 in 2023, then skyrocketed by 150.0% to $45000.0 in 2024, then plummeted by 84.44% to $7000.0 in 2025.
  • Its Capital Expenditures stands at $7000.0 for Q2 2025, versus $10000.0 for Q1 2025 and $45000.0 for Q2 2024.